2016 American Transplant Congress
Early Proteomic Predictors of Late Chronic Kidney Disease in Liver Transplant Recipients.
1Northwestern, Chicago; 2Baylor, Dallas.
Background: A high proportion of patients develop chronic kidney disease (CKD) after liver transplantation (LT). However, the ability to better select patients for nephroprotective interventions…2016 American Transplant Congress
The Effect of DRI and KDPI on Outcomes of High MELD Patients Undergoing Simultaneous Liver Kidney Transplant.
Background: Patients with a high Model for End Stage Liver Disease (MELD) score have an increased risk for dying without transplant. Renal function worsens secondary…2016 American Transplant Congress
Predictors of Patient Uncertainty Regarding Treatment Options Among End Stage Renal Disease Patients Evaluated for Kidney Transplantation.
Background: Although kidney transplantation (KTx) provides a significant survival benefit over long-term dialysis, many end stage renal disease (ESRD) patients are uncertain or conflicted about…2016 American Transplant Congress
A Nationwide Analysis of Reoperation After kidney Transplant.
Surgery, Division of Transplant Surgery, University of Miami School of Medicine, Miami, FL.
ObjectivesWe aim to report the rate and short-term outcomes of patients undergoing reoperation following kidney transplant in the United States.MethodsThe NIS database was used to…2016 American Transplant Congress
Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma in Cirrhotic Livers.
University of California, San Francisco, San Francisco, CA.
Background: Current guidelines recommend ultrasound (US) for hepatocellular carcinoma (HCC) surveillance in cirrhotic livers. However, certain patient and disease characteristics may pose a technical challenge…2016 American Transplant Congress
Long-Term Assessment of the Safety and Efficacy of IVIG and Rituximab-Based Desensitization (DES).
Comprehensive Transplantation Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Introduction: HLA sensitized patients constitute a growing number of ESRD patients with an immunologic barrier to successful transplantation. Desensitization (DES) therapies have emerged to address…2016 American Transplant Congress
Muscle Function, Mass, and Quality in Obese Liver Transplant Candidates: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.
Background: Sarcopenia, or severe loss of muscle mass, is common in cirrhotics and adversely affects quality of life and transplant outcomes. Obese liver transplant(LT) candidates…2016 American Transplant Congress
Engineering a “Hybrid Thymus” to Promote Transplant Tolerance.
Purpose: Targeting the process of central (thymic) selection of developing T lymphocytes is the key tolerogenic mechanism of bone marrow transplantation (BM-Tx)-based protocols for transplant…2016 American Transplant Congress
CMV Immune Monitoring with a CMV ELISPOT Test in Kidney Transplant Patients.
Department of Renal Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Cytomegalovirus (CMV) is an important opportunistic infection in kidney transplant recipients (KTR). Whilst pre-emptive or prophylactic anti-viral regime reduce CMV complications, drug toxicity and resistance…2016 American Transplant Congress
Conditional Deletion of mTOR in Myeloid Cells Inhibits Chronic Allograft Rejection – A Novel Role for Macrophages in Transplant Vasculopathy.
Most transplants eventually lost to chronic rejection under potent immunosuppression therapies where activation of innate immunity is suspected to play a major role in graft…
- « Previous Page
- 1
- …
- 120
- 121
- 122
- 123
- 124
- …
- 180
- Next Page »